Genetic risk factors seem to play a role in sporadic Parkinson's disease (PD), maybe
triggering oxidative stress and excitotoxicity within substantia nigra. However, genetic factors …

A double‐blind, randomized electromyographic investigation was conducted of the effects of
cerebral ganglioside treatment on patients suffering from diabetic or alcoholic …

The authors studied the effects of lisuride hydrogen maleate (lisuride) on the hyperkinesias
of 11 patients suffering from Huntington's chorea (HC). In all patients, acute injection of 150 …

The authors tested the effects of 2‐Br‐ergocriptine (bromocriptine, CB‐154), a drug which
exerts a mixed agonist‐antagonist activity on the dopaminergic receptors, in 12 patients with …

Cannabidiol (CBD), the main non-psychoactive component of Cannabis sativa L., is widely
used in therapy for the treatment of different diseases and as an adjuvant drug. Our aim was …

Abstract 117 patients with multi-infarct dementia were treated for 90 days with either choline
alfoscerate or cytidine diphosphocholine. At the baseline check-up and after 45 and 90 days …

The efficacy and safety of alpidem, a new anxiolytic imidazopyridine, were compared with
those of placebo in anxious elderly patients (65–80 years) by means of a randomized …

Sleep induction has been studied in humans after the administration of apomorphine, a
direct stimulant of the central dopaminergic system. The drug induced sleep and vomiting in …

BackgroundWe investigated whether a new non-benzodiazepine anti-anxiety drug, alpidem,
produces weaker withdrawal symptoms than alprazolam. MethodUnder a double-blind …

The F‐wave velocity in the central segment (axilla to spinal cord) was studied employing the
“collision technique” described by Kimura (1974), and compared with the conduction …